ArticleJournal of cellular and molecular medicine2022

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer.

Dávid Keresztes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.